Department of Psychiatry, College of Physicians and Surgeons, Unit 43, Columbia University, New York, NY 10032, USA.
Drug Alcohol Depend. 2010 Nov 1;112(1-2):33-8. doi: 10.1016/j.drugalcdep.2010.05.006. Epub 2010 Jun 8.
To investigate trends in rates of ecstasy use among US adolescents from 1999 to 2008, and to examine the associations between the major sociodemographic factors, especially gender, and ecstasy use, during this period.
The adolescent subsamples (age 12-17) from 1999 to 2008 NHSDA/NSDUH surveys were used for the current study. Data from adolescents' self-reports on use of ecstasy and of other drugs, as well as sociodemographic characteristics, were used in the analyses.
There was an increasing trend in adolescent ecstasy use from 1999 to 2002, which was followed by a decreasing trend from 2002 to 2005, and a slight rise from 2005 to 2008. In contrast to some other drugs, ecstasy was more likely to be used by girls than by boys. This gender difference persisted over the 10-year period and could not be explained by other demographic factors.
Given the known health consequences of ecstasy use, especially for females, the observed gender difference in adolescent ecstasy use should be taken into account by drug prevention and intervention programs.
调查 1999 年至 2008 年美国青少年迷幻药使用率的趋势，并在此期间研究主要社会人口因素（尤其是性别）与迷幻药使用之间的关系。
本研究使用了 1999 年至 2008 年 NHSDA/NSDUH 调查中的青少年亚样本（12-17 岁）。分析中使用了青少年自我报告的迷幻药和其他药物使用情况以及社会人口特征数据。
青少年迷幻药使用呈上升趋势，从 1999 年到 2002 年，然后从 2002 年到 2005 年呈下降趋势，从 2005 年到 2008 年略有上升。与其他一些药物不同，迷幻药更可能被女孩使用，而不是男孩。这种性别差异在 10 年期间持续存在，不能用其他人口统计学因素来解释。
鉴于迷幻药使用的已知健康后果，特别是对女性的影响，应该考虑到青少年迷幻药使用中的这种性别差异，药物预防和干预计划应该考虑到这一点。
